{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:50Z","timestamp":1789142510377,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72074049"],"award-info":[{"award-number":["72074049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-025-02376-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:49:53Z","timestamp":1752137393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health-related quality of life of patients with multiple sclerosis in China: a national online survey"],"prefix":"10.1186","volume":"23","author":[{"given":"Xinyi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanqi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"2376_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40261-019-00750-3","volume":"39","author":"Y Xu","year":"2019","unstructured":"Xu Y, Mao N, Chirikov V, Du F, Yeh YC, Liu L, Liu R, Gao X. Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China. Clin Drug Investig. 2019;39:331\u201340. https:\/\/doi.org\/10.1007\/s40261-019-00750-3.","journal-title":"Clin Drug Investig"},{"key":"2376_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816\u201321. https:\/\/doi.org\/10.1177\/1352458520970841.","journal-title":"Mult Scler"},{"key":"2376_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2020.07.022","author":"GX Zhang","year":"2020","unstructured":"Zhang GX, Carrillo-Vico A, Zhang WT, Gao SS, Izquierdo Ayuso G. Incidence and prevalence of multiple sclerosis in China and other Asian countries. Neurologia (Engl Ed). 2020. https:\/\/doi.org\/10.1016\/j.nrl.2020.07.022.","journal-title":"Neurologia (Engl Ed)"},{"key":"2376_CR4","doi-asserted-by":"publisher","first-page":"651511","DOI":"10.3389\/fneur.2021.651511","volume":"12","author":"R Zhou","year":"2021","unstructured":"Zhou R, Zeng Q, Yang H, Xu Y, Tan G, Liu H, Wang L, Zhou H, Zhang M, Feng J, Jin T, Zhang X, Wang J, Zhang X, Gao F, Yang C, Bu B, Li C, Zhang M, Dong H, Lin A, Liu W, Wu L, Wang M, Tang Y, Wang H, Long Y, Wang Z, Zheng W. Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018. Front Neurol. 2021;12:651511. https:\/\/doi.org\/10.3389\/fneur.2021.651511.","journal-title":"Front Neurol"},{"key":"2376_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.wnl.0000260695.72980.b7","volume":"68","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Miao L, Zhang J, Ding SJ, Liu ZG, Wang X, Sun XJ, Zhao ZX, Song YJ, Ding XY, Guo ZL, Yang Y, Chen SD, Jiang GX, Fredrikson S. A population-based survey of multiple sclerosis in Shanghai, China. Neurology. 2007;68:1495\u2013500. https:\/\/doi.org\/10.1212\/01.wnl.0000260695.72980.b7.","journal-title":"Neurology"},{"key":"2376_CR6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/ene.14764","volume":"28","author":"L Xu","year":"2021","unstructured":"Xu L, Chen L, Wang S, Feng J, Liu L, Liu G, Wang J, Zhan S, Fan D. Urban prevalence of multiple sclerosis in China: A population-based study in six provinces. Eur J Neurol. 2021;28:1636\u201344. https:\/\/doi.org\/10.1111\/ene.14764.","journal-title":"Eur J Neurol"},{"key":"2376_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1524-4733.2006.00144.x","volume":"10","author":"M Orme","year":"2007","unstructured":"Orme M, Kerrigan J, Tyas D, Russell N, Nixon R. The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK. Value Health. 2007;10:54\u201360. https:\/\/doi.org\/10.1111\/j.1524-4733.2006.00144.x.","journal-title":"Value Health"},{"key":"2376_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12883-019-1495-z","volume":"19","author":"JA Nicholas","year":"2019","unstructured":"Nicholas JA, Electricwala B, Lee LK, Johnson KM. Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data. BMC Neurol. 2019;19:258. https:\/\/doi.org\/10.1186\/s12883-019-1495-z.","journal-title":"BMC Neurol"},{"key":"2376_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0000000000000921","volume":"34","author":"M Calabrese","year":"2021","unstructured":"Calabrese M, Marastoni D, Crescenzo F, Scalfari A. Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients. Curr Opin Neurol. 2021;34:277\u201385. https:\/\/doi.org\/10.1097\/WCO.0000000000000921.","journal-title":"Curr Opin Neurol"},{"key":"2376_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/smi.2432","volume":"29","author":"K Chen","year":"2013","unstructured":"Chen K, Fan Y, Hu R, Yang T, Li K. Impact of depression, fatigue and disability on quality of life in Chinese patients with multiple sclerosis. Stress Health. 2013;29:108\u201312. https:\/\/doi.org\/10.1002\/smi.2432.","journal-title":"Stress Health"},{"key":"2376_CR11","doi-asserted-by":"publisher","first-page":"104626","DOI":"10.1016\/j.msard.2023.104626","volume":"73","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Wang W, Chen W, Xu Y. The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study. Mult Scler Relat Disord. 2023;73:104626. https:\/\/doi.org\/10.1016\/j.msard.2023.104626.","journal-title":"Mult Scler Relat Disord"},{"key":"2376_CR12","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1177\/1352458514528760","volume":"20","author":"P Flachenecker","year":"2014","unstructured":"Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli O, Consortium EU. Multiple sclerosis registries in Europe - results of a systematic survey. Mult Scler. 2014;20:1523\u201332. https:\/\/doi.org\/10.1177\/1352458514528760.","journal-title":"Mult Scler"},{"key":"2376_CR13","doi-asserted-by":"publisher","first-page":"e50147","DOI":"10.2196\/50147","volume":"9","author":"RH Xu","year":"2023","unstructured":"Xu RH, Ng SSM, Luo N, Dong D, Zhang S. Measurement of Health-Related Quality of Life in Individuals With Rare Diseases in China: Nation-Wide Online Survey. JMIR Public Health Surveill. 2023;9:e50147. https:\/\/doi.org\/10.2196\/50147.","journal-title":"JMIR Public Health Surveill"},{"key":"2376_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271\u201392. https:\/\/doi.org\/10.1016\/s0167-6296(01)00130-8.","journal-title":"J Health Econ"},{"key":"2376_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13690-021-00561-z","volume":"79","author":"LA Visser","year":"2021","unstructured":"Visser LA, Louapre C, Uyl-de Groot CA, Redekop WK. Health-related quality of life of multiple sclerosis patients: a European multi-country study. Arch Public Health. 2021;79:39. https:\/\/doi.org\/10.1186\/s13690-021-00561-z.","journal-title":"Arch Public Health"},{"key":"2376_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jval.2018.08.002","volume":"22","author":"J Eriksson","year":"2019","unstructured":"Eriksson J, Kobelt G, Gannedahl M, Berg J. Association between Disability, Cognition, Fatigue, EQ-5D-3L Domains, and Utilities Estimated with Different Western European Value Sets in Patients with Multiple Sclerosis. Value Health. 2019;22:231\u20138. https:\/\/doi.org\/10.1016\/j.jval.2018.08.002.","journal-title":"Value Health"},{"key":"2376_CR17","doi-asserted-by":"publisher","first-page":"102358","DOI":"10.1016\/j.msard.2020.102358","volume":"44","author":"H Ahmad","year":"2020","unstructured":"Ahmad H, van der Mei I, Taylor BV, Campbell JA, Palmer AJ. Measuring the health-related quality of life in Australians with multiple sclerosis using the assessment of quality of life-8-dimension (AQoL-8D) multi-attribute utility instrument. Mult Scler Relat Disord. 2020;44:102358. https:\/\/doi.org\/10.1016\/j.msard.2020.102358.","journal-title":"Mult Scler Relat Disord"},{"key":"2376_CR18","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s11136-020-02505-6","volume":"29","author":"JA Campbell","year":"2020","unstructured":"Campbell JA, Jelinek GA, Weiland TJ, Nag N, Neate SL, Palmer AJ, Mulhern B, De Livera A, Simpson-Yap S. SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis. Qual Life Res. 2020;29:2509\u201327. https:\/\/doi.org\/10.1007\/s11136-020-02505-6.","journal-title":"Qual Life Res"},{"key":"2376_CR19","doi-asserted-by":"publisher","first-page":"105635","DOI":"10.1016\/j.msard.2024.105635","volume":"86","author":"J Dahham","year":"2024","unstructured":"Dahham J, Hiligsmann M, Kremer I, Khoury SJ, Darwish H, Hosseini H, Hallit S, Evers S, Rizk R. Health-related quality of life and utilities among Lebanese patients with Multiple Sclerosis: A cross-sectional study. Mult Scler Relat Dis. 2024;86:105635. https:\/\/doi.org\/10.1016\/j.msard.2024.105635 (https:\/\/doi.org\/ARTN).","journal-title":"Mult Scler Relat Dis"},{"key":"2376_CR20","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1007\/s11136-023-03486-y","volume":"32","author":"H Ahmad","year":"2023","unstructured":"Ahmad H, Campbell JA, van der Mei I, Taylor BV, Xia Q, Zhao T, Palmer AJ. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models. Qual Life Res. 2023;32:3373\u201387. https:\/\/doi.org\/10.1007\/s11136-023-03486-y.","journal-title":"Qual Life Res"},{"key":"2376_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/MLR.0b013e31817d69a6","volume":"46","author":"S McPhail","year":"2008","unstructured":"McPhail S, Beller E, Haines T. Two perspectives of proxy reporting of health-related quality of life using the Euroqol-5D, an investigation of agreement. Med Care. 2008;46:1140\u20138. https:\/\/doi.org\/10.1097\/MLR.0b013e31817d69a6.","journal-title":"Med Care"},{"key":"2376_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11136-004-1920-6","volume":"14","author":"S Bryan","year":"2005","unstructured":"Bryan S, Hardyman W, Bentham P, Buckley A, Laight A. Proxy completion of EQ-5D in patients with dementia. Qual Life Res. 2005;14:107\u201318. https:\/\/doi.org\/10.1007\/s11136-004-1920-6.","journal-title":"Qual Life Res"},{"key":"2376_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ggi.12108","volume":"14","author":"A Diaz-Redondo","year":"2014","unstructured":"Diaz-Redondo A, Rodriguez-Blazquez C, Ayala A, Martinez-Martin P, Forjaz MJ, Spanish Research Group on Quality of L, Aging. Geriatr Gerontol Int. 2014;14:346\u201353. https:\/\/doi.org\/10.1111\/ggi.12108.","journal-title":"Geriatr Gerontol Int"},{"key":"2376_CR24","doi-asserted-by":"publisher","first-page":"e65640","DOI":"10.1371\/journal.pone.0065640","volume":"8","author":"KH Jones","year":"2013","unstructured":"Jones KH, Ford DV, Jones PA, John A, Middleton RM, Lockhart-Jones H, Peng J, Osborne LA, Noble JG. How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register. Plos One. 2013;8:e65640. https:\/\/doi.org\/10.1371\/journal.pone.0065640 (https:\/\/doi.org\/ARTN).","journal-title":"Plos One"},{"key":"2376_CR25","doi-asserted-by":"publisher","first-page":"631989","DOI":"10.1155\/2015\/631989","volume":"2015","author":"BG Vickrey","year":"2015","unstructured":"Vickrey BG, Lee L, Moore F, Moriarty P. EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon beta -1a. Mult Scler Int. 2015;2015:631989. https:\/\/doi.org\/10.1155\/2015\/631989.","journal-title":"Mult Scler Int"},{"key":"2376_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00415-022-11453-9","volume":"270","author":"M Niino","year":"2023","unstructured":"Niino M, Fukumoto S, Okuno T, Sanjo N, Fukaura H, Mori M, Ohashi T, Takeuchi H, Shimizu Y, Fujimori J, Kawachi I, Kira JI, Takahashi E, Miyazaki Y, Mifune N. Health-related quality of life in Japanese patients with multiple sclerosis. J Neurol. 2023;270:1011\u20138. https:\/\/doi.org\/10.1007\/s00415-022-11453-9.","journal-title":"J Neurol"},{"key":"2376_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s40001-023-01185-5","volume":"28","author":"V Gitman","year":"2023","unstructured":"Gitman V, Moss K, Hodgson D. A systematic review and meta-analysis of the effects of non-pharmacological interventions on quality of life in adults with multiple sclerosis. Eur J Med Res. 2023;28:294. https:\/\/doi.org\/10.1186\/s40001-023-01185-5.","journal-title":"Eur J Med Res"},{"key":"2376_CR28","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.29399\/npa.23412","volume":"55","author":"S Sen","year":"2018","unstructured":"Sen S. Neurostatus and EDSS Calculation with Cases. Noro Psikiyatr Ars. 2018;55:S80\u20133. https:\/\/doi.org\/10.29399\/npa.23412.","journal-title":"Noro Psikiyatr Ars."},{"key":"2376_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12883-022-02700-7","volume":"22","author":"Z Hosseini","year":"2022","unstructured":"Hosseini Z, Homayuni A, Etemadifar M. Barriers to quality of life in patients with multiple sclerosis: a qualitative study. BMC Neurol. 2022;22:174. https:\/\/doi.org\/10.1186\/s12883-022-02700-7.","journal-title":"BMC Neurol"},{"key":"2376_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12264-023-01135-5","volume":"40","author":"Y Jia","year":"2024","unstructured":"Jia Y, Qiao X, Zhao J, Li H, Hu S, Hu M. Disease Burden and Costs Associated with Multiple Sclerosis in China: A Cross-sectional Analysis of Nationwide Survey Data. Neurosci Bull. 2024;40:533\u20138. https:\/\/doi.org\/10.1007\/s12264-023-01135-5.","journal-title":"Neurosci Bull"},{"key":"2376_CR31","unstructured":"Hongmian cancers and rare disorders charity foundation of Guangzhou. Home. Hongmian cancers and rare disorders charity foundation of Guangzhou; [cited 2023 Mar 30]. Available from: https:\/\/www.hongmiancf.org.cn."},{"key":"2376_CR32","doi-asserted-by":"publisher","first-page":"103312","DOI":"10.1016\/j.autrev.2023.103312","volume":"22","author":"FF Konen","year":"2023","unstructured":"Konen FF, Mohn N, Witte T, Schefzyk M, Wiestler M, Lovric S, Hufendiek K, Schwenkenbecher P, Suhs KW, Friese MA, Klotz L, Pul R, Pawlitzki M, Hagin D, Kleinschnitz C, Meuth SG, Skripuletz T. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmun Rev. 2023;22:103312. https:\/\/doi.org\/10.1016\/j.autrev.2023.103312.","journal-title":"Autoimmun Rev"},{"key":"2376_CR33","doi-asserted-by":"publisher","unstructured":"Jia Y, Hu M, Li H, Qiao X. Study on Disease and Economic Burden of Multiple Sclerosis Patients in China [in Chinese]. Chinese Health Insurance. 2022;(07):93-98. https:\/\/doi.org\/10.19546\/j.issn.1674-3830.2022.7.018.","DOI":"10.19546\/j.issn.1674-3830.2022.7.018"},{"key":"2376_CR34","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res"},{"key":"2376_CR35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L Value Set for China. Value Health. 2017;20:662\u20139. https:\/\/doi.org\/10.1016\/j.jval.2016.11.016.","journal-title":"Value Health"},{"key":"2376_CR36","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.msard.2020.102693","volume":"48","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang Y, Du Q, Chen H, Shi Z, Wang J, Qiu Y, Yan C, Zhou H. Differences in physical, mental, and social functions between males and females in multiple sclerosis: A multicenter cross-sectional study in China. Mult Scler Relat Disord. 2021;48:102693. https:\/\/doi.org\/10.1016\/j.msard.2020.102693.","journal-title":"Mult Scler Relat Disord"},{"key":"2376_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2377-14-58","volume":"14","author":"S Meyer-Moock","year":"2014","unstructured":"Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 2014;14:58. https:\/\/doi.org\/10.1186\/1471-2377-14-58.","journal-title":"BMC Neurol"},{"key":"2376_CR38","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.msard.2020.102148","volume":"42","author":"M Kaufmann","year":"2020","unstructured":"Kaufmann M, Salmen A, Barin L, Puhan MA, Calabrese P, Kamm CP, Gobbi C, Kuhle J, Manjaly ZM, Ajdacic-Gross V, Schafroth S, Bottignole B, Ammann S, Zecca C, D\u2019Souza M, von Wyl V, Swiss Multiple Sclerosis R. Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories. Mult Scler Relat Disord. 2020;42:102148. https:\/\/doi.org\/10.1016\/j.msard.2020.102148.","journal-title":"Mult Scler Relat Disord"},{"key":"2376_CR39","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","volume":"77","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Berg J, Lindgren P, Fredrikson S, J\u00f6nsson B. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosur Ps. 2006;77:918\u201326. https:\/\/doi.org\/10.1136\/jnnp.2006.090365.","journal-title":"J Neurol Neurosur Ps"},{"key":"2376_CR40","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, Grp MS, Sclerosis EM. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler J. 2017;23:1123\u201336. https:\/\/doi.org\/10.1177\/1352458517694432.","journal-title":"Mult Scler J"},{"key":"2376_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10198-023-01566-x","volume":"25","author":"ST Xie","year":"2024","unstructured":"Xie ST, Wu J, Chen G. Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population. Eur J Health Econ. 2024;25:7\u201319. https:\/\/doi.org\/10.1007\/s10198-023-01566-x.","journal-title":"Eur J Health Econ"},{"key":"2376_CR42","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jval.2024.04.014","volume":"27","author":"D-L Li","year":"2024","unstructured":"Li D-L, Wang Z-T, Nie X-Y, Luo N, Wu Y-B, Pan C-W, Wang P. EQ-5D-5L Population Norms for China Derived From a National Health Survey. Value Health. 2024;27:1108\u201320. https:\/\/doi.org\/10.1016\/j.jval.2024.04.014.","journal-title":"Value Health"},{"key":"2376_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40273-020-00964-w","volume":"39","author":"L Hernandez","year":"2021","unstructured":"Hernandez L, O\u2019Donnell M, Postma M, Msoac,. Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies. Pharmacoeconomics. 2021;39:243\u201356. https:\/\/doi.org\/10.1007\/s40273-020-00964-w.","journal-title":"Pharmacoeconomics"},{"key":"2376_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40273-021-01023-8","volume":"39","author":"N Schur","year":"2021","unstructured":"Schur N, Gudala K, Vudumula U, Vadapalle S, Bhadhuri A, Casanova A, Adlard N, Schwenkglenks M. Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland. Pharmacoeconomics. 2021;39:563\u201377. https:\/\/doi.org\/10.1007\/s40273-021-01023-8.","journal-title":"Pharmacoeconomics"},{"key":"2376_CR45","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00415-019-09489-5","volume":"268","author":"H Inojosa","year":"2021","unstructured":"Inojosa H, Proschmann U, Akgun K, Ziemssen T. A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition. J Neurol. 2021;268:1210\u201321. https:\/\/doi.org\/10.1007\/s00415-019-09489-5.","journal-title":"J Neurol"},{"issue":"141\u2013151","key":"2376_CR46","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/j.apmr.2015.07.022","volume":"97","author":"E Campbell","year":"2016","unstructured":"Campbell E, Coulter EH, Mattison PG, Miller L, McFadyen A, Paul L. Physiotherapy Rehabilitation for People With Progressive Multiple Sclerosis: A Systematic Review. Arch Phys Med Rehabil. 2016;97(141\u2013151):e143. https:\/\/doi.org\/10.1016\/j.apmr.2015.07.022.","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02376-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-025-02376-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02376-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:49:56Z","timestamp":1752137396000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-025-02376-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2376"],"URL":"https:\/\/doi.org\/10.1186\/s12955-025-02376-w","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of the School of Public Health, Fudan University (IRB00002408 & FWA00002399). No interventions were implemented on study interviewees. Informed consent was obtained from all study participants through a web-based questionnaire system, and their rights and privacy were respected and protected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All named authors have contributed substantially to the manuscript and have approved the submitted copy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}